Lords Mark Partners ARKALL for Caribbean Healthcare Expansion
Lords Mark Industries Ltd has entered a strategic collaboration with ARKALL Holdings Ltd, a Caribbean-based entity, to establish and operate pathology laboratories and commercialize its medical devices and healthcare portfolio across the Caribbean region. ARKALL Holdings will provide the necessary investment for this expansion, which is planned in phases over three years, starting with Trinidad & Tobago. Lords Mark will supply its IVD products, medical equipment, and provide technical support. The company projects this phased rollout could generate approximately US$100 million in export revenue between FY 2026-27 and FY 2030-31. The estimated pathology and diagnostics market opportunity in the identified Caribbean markets is around US$1.24 billion.
Key Highlights
- Strategic collaboration with ARKALL Holdings for Caribbean healthcare market entry.
- ARKALL to fund expansion; Lords Mark to provide products and technical support.
- Phased expansion starting with Trinidad & Tobago over three years.
- Projected US$100 million export revenue potential by FY 2030-31.
- Estimated US$1.24 billion market opportunity in Caribbean diagnostics.
Price Impact
More from LORDSMARK